Senator Burr has stepped up for the dietary supplement industry in a big way. He recently introduced a clean FDA reauthorization bill that does not include controversial provisions that would require pre-market approval and drive up the cost of products.

His bill, the Food and Drug Administration Simple Reauthorization Act, would reauthorize the FDA's prescription drug, generic drug, biosimilar, and medical device user fee agreements, ensuring Americans continue access to innovative treatments and therapies. 

But he needs our help building support and momentum to ensure his bill becomes law, which is why we are urging you to write your members of Congress TODAY to encourage them to support Senator Burr's efforts.

This legislation will keep FDA's critical operations running while ensuring the FDA is accountable to its performance commitments. Registering your support today takes a few clicks, so don't wait.

Thank you,

Daniel Fabricant, Ph.D. 

President and CEO

Natural Products Association.